在喘进展中,KIF1B调节了NLRP3介导的热
Junchao Wang1, Yuan Gao1, Jing Li1
1Department of Pediatrics, the Third People's Hospital of Hubei Province, Hubei Province, China.
Journal of cellular and molecular medicine
|December 12, 2025
概括
素家族成员1B (KIF1B) 通过激活NLRP3炎症酶依赖性热死来驱动喘炎症. 抑制KIF1B可减少气道炎症和损伤,为喘提供潜在的治疗点.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 喘是一种慢性呼吸道疾病,分子机制尚不清楚.
- 目前的治疗方法无法治愈喘.
研究的目的:
- 为了研究KIF1B在喘发病过程中的作用.
- 阐明KIF1B在调节气道炎症和热的分子机制.
主要方法:
- 对人类喘患者数据和细胞/小鼠模型的分析.
- 进行KIF1B倒置和NLRP3过度表达实验.
- 评估烧灭症标志物和细胞因子水平.
主要成果:
- 在喘中,KIF1B的表达升高.
- 抑制KIF1B可以减少炎症,氧化应激和热.
- KIF1B通过NLRP3炎症酶激活促进喘.
结论:
- KIF1B是呼吸道炎症和喘中热的关键调节者.
- 向KIF1B为控制喘提供了一个潜在的治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K


